Evidence map›Paper›PMID 40737085›Full record

ArticleNucleic acids research2025

The function of MYC in base excision repair protects against RAS-induced senescence.

Camila C F Faraco, Wanting Zhu, Anne-Marie Fortier, Zubaidah M Ramdzan, Elise Vickridge, Virakbott Ong, Félix Goudreau, Billel Djerir, Jérôme Bellemare, Shujing Gu and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Camila C F FaracoGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Wanting ZhuGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Anne-Marie FortierGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Zubaidah M RamdzanGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Elise VickridgeGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.ORCID 0000-0001-8537-5183
Virakbott OngGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Félix GoudreauDepartment of Biology and Cancer Research Institute, Université de Sherbrooke, Sherbrooke, Quebec, J1K2R1, Canada.
Billel DjerirDepartment of Biology and Cancer Research Institute, Université de Sherbrooke, Sherbrooke, Quebec, J1K2R1, Canada.
Jérôme BellemareDepartment of Biology and Cancer Research Institute, Université de Sherbrooke, Sherbrooke, Quebec, J1K2R1, Canada.
Shujing GuGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Huanyi ZhangGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Brittany L CarrollDepartment of Biochemistry, McGill University, Montreal, Quebec, H3A 1A1, Canada.
Shreya S KrishnanDepartment of Biochemistry, McGill University, Montreal, Quebec, H3A 1A1, Canada.
Lam LeduyGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Alba GuarnéDepartment of Biochemistry, McGill University, Montreal, Quebec, H3A 1A1, Canada.ORCID 0000-0003-4906-9132
Morag ParkGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.
Alexandre MaréchalDepartment of Biology and Cancer Research Institute, Université de Sherbrooke, Sherbrooke, Quebec, J1K2R1, Canada.
Alain NepveuGoodman Cancer Institute, McGill University, Montreal, H3A 1A3, Quebec, Canada.ORCID 0000-0002-6125-0850

Funding

Canadian Institutes of Health Research (CIHR) RGPIN-2023-04565Canadian Institutes of Health Research (CIHR) RGPIN-2023-04759Canadian Tumor Repository Network (CTRNet)McGill 263189NSERCQuébec Breast Cancer FoundationRéseau de Recherche sur le Cancer of the Fonds de Recherche du Québec-Santé
6 · The paper itself

Abstract

The MYC and RAS oncogenes were found early on to cooperate in the transformation of nonimmortalized primary cells, and in tumor development in transgenic mouse models. MYC prevents RAS-induced senescence. Moreover, tumor regression resulting from the suppression of MYC expression is associated with cellular senescence. How MYC prevents RAS-induced senescence and why suppression of MYC in tumors causes senescence remains to be elucidated. Here, we show that MYC interacts with the Pol β DNA polymerase and stimulates its enzymatic activities to accelerate the repair of oxidative DNA damage by the base excision repair (BER) pathway, thereby enabling RAS-driven cancer cells to avoid senescence and continue to proliferate despite producing excess levels of reactive oxygen species. The carboxy-terminal domain of MYC, which is needed for heterodimerization with its MAX partner and DNA binding, is not required for the DNA repair activity of MYC. Ectopic expression of MYCΔCTD accelerates DNA repair, protects against RAS-induced senescence, and cooperates with RAS in the transformation of primary cells, whereas MYC mutants inactive in DNA repair exhibit weaker or no activity in these assays. These results demonstrate that the function of MYC in BER plays an important role in the MYC-RAS cooperation.

Indexed as

Cellular SenescenceDNA RepairProto-Oncogene Proteins c-mycras ProteinsAnimalsCell Transformation, NeoplasticDNA DamageDNA Polymerase betaExcision RepairHumansMiceReactive Oxygen SpeciesDNA Polymerase betaProto-Oncogene Proteins c-mycras ProteinsReactive Oxygen Species

Identifiers

PMID40737085
PMCPMC12309371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.